Science Events in Boston
Stay up-to-date with all of the life science events taking place in the Greater Boston area with the Science in Boston events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Boston. We even cover science pub nights and science fundraisers!
If you’re interested in promoting your life science event on the Science in Boston events calendar, please use our event submission form.
- This event has passed.
New England CEPAC Meeting: Duchenne Muscular Dystrophy
July 25, 2019 - 10:00 am - 4:00 pm
The New England Comparative Effectiveness Public Advisory Council (CEPAC), a core program of the Institute for Clinical and Economic Review (ICER), will hold a public meeting on July 25, 2019 to consider the comparative clinical effectiveness and value of deflazacort (Emflaza®, PTC Therapeutics), eteplirsen (Exondys 51®, Sarepta) and golodirsen (Sarepta)for the treatment of Duchenne muscular dystrophy (DMD).
DMD is a fatal, X-linked neuromuscular disease caused by mutations in the dystrophin gene that result in progressive loss of muscle function, including skeletal and cardiac function. It is the most common pediatric muscular dystrophy, affecting about 400 to 600 boys per year in the US.
This is ICER’s first review of treatments for DMD. A presentation of the evidence will be followed by a public comment period and deliberations and votes by the New England CEPAC. The votes will be followed by a policy roundtable discussion.
A list of key dates for stakeholder engagement opportunities and other important information associated with the review of deflazacort, eteplirsen, and golodirsen for DMD can be found on ICER’s website at https://icer-review.org/topic/duchenne-muscular-dystrophy/.
